| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in OKUR over the last quarter tilts toward selling: insiders offloaded a net 389 shares worth roughly $1K.
Classified under Biotechnology (Health Care sector), OKUR's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 20.6K | - | - | |
| CFO | 18.5K | $55.0K | - | |
| Dir | 15.3K | - | - | |
| CEO | 11.2K | $33.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2024 | Leonard Braden Michael59 | 10% Owner | Buy | 271,826 | $1.40 | $380,597.79 | +10.2% | +17.6% | -81.8% | |
| May 14, 2024 | Leonard Braden Michael59 | 10% Owner | Buy | 414,281 | $1.54 | $639,578.36 | +18.3% | -17.3% | -88.7% | |
| Aug 28, 2023 | Hall Ashley | Chief Development Officer | Sale+OE | 15,625 | $6.28 | $98,057.81 | -28.3% | -2.3% | -74.2% | |
| Jun 23, 2023 | Novo Holdings A/s58 | 10% Owner | Sell | 100,000 | $7.10 | $709,740.00 | -2.9% | +0.6% | -77.0% | |
| May 8, 2023 | O'Donnell Niall | Director | Buy | 125,000 | $8.00 | $1,000,000.00 | +6.1% | -28.4% | -81.4% | |
| Sep 1, 2022 | Cruse Michael59 | Chief Operating Officer | Buy | 7,500 | $3.39 | $25,447.50 | +121.0% | -36.3% | +80.6% | |
| Aug 31, 2022 | Cruse Michael59 | Chief Operating Officer | Buy | 7,255 | $3.20 | $23,243.39 | -685.7% | -30.5% | +91.1% | |
| Aug 25, 2021 | Cruse Michael59 | Senior Vp-corporate Operations | Buy | 2,500 | $7.45 | $18,616.00 | New | +13.2% | -52.4% | |
| Aug 25, 2021 | Flesher Gregory J. | President and CEO | Buy | 8,000 | $8.00 | $64,000.00 | New | +13.2% | -52.4% | |
| Aug 25, 2021 | Jindal Vineet R. | Chief Financial Officer | Buy | 5,000 | $7.44 | $37,176.50 | New | +13.2% | -52.4% |